Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study

• Aurélie Di Bartolomeo,

  Affiliation Department of Gynaecology and Obstetrics, University Hospital, Saint Etienne, France

  ⨯
• Céline Chauleur,

  Affiliations Department of Gynaecology and Obstetrics, University Hospital, Saint Etienne, France, INSERM UMR 1059, Saint Etienne University Jean Monnet, Saint Etienne, France

  ⨯
• Jean-Christophe Gris,

  Affiliations Laboratory of Haematology, University Hospital, Nîmes, France, Research Unit EA2992, Montpellier University, Montpellier, France

  ⨯
• Céline Chapelle,

  Affiliations INSERM UMR 1059, Saint Etienne University Jean Monnet, Saint Etienne, France, Clinical Pharmacology Unit, University Hospital, Saint Etienne, France

  ⨯
• Edouard Noblot,

  Affiliation Department of Gynaecology and Obstetrics, University Hospital, Saint Etienne, France

  ⨯
• Silvy Laporte,

  Affiliations INSERM UMR 1059, Saint Etienne University Jean Monnet, Saint Etienne, France, Clinical Pharmacology Unit, University Hospital, Saint Etienne, France

  ⨯
• Tiphaine Raia-Barjat

  * E-mail: tiphaine.barjat@chu-st-etienne.fr

  Affiliations Department of Gynaecology and Obstetrics, University Hospital, Saint Etienne, France, INSERM UMR 1059, Saint Etienne University Jean Monnet, Saint Etienne, France

  http://orcid.org/0000-0002-4408-6075

  ⨯